ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975